PMID- 31917467
OWN - NLM
STAT- MEDLINE
DCOM- 20201221
LR  - 20210110
IS  - 1932-8737 (Electronic)
IS  - 0160-9289 (Print)
IS  - 0160-9289 (Linking)
VI  - 43
IP  - 4
DP  - 2020 Apr
TI  - Intermittent vs continuous electrocardiogram event recording for detection of 
      atrial fibrillation-Compliance and ease of use in an ambulatory elderly 
      population.
PG  - 355-362
LID - 10.1002/clc.23323 [doi]
AB  - BACKGROUND: There are many atrial fibrillation (AF) screening devices available. 
      Validation studies have mainly been performed in optimal settings in the young 
      population. HYPOTHESIS: We aim to compare the yield of AF detection, compliance, 
      and patient-based experience in an ambulatory elderly population by using 
      intermittent electrocardiogram (ECG) recordings and continuous event recording 
      simultaneously. METHODS: The study participants were part of the STROKESTOP II 
      study, a Swedish screening study for AF. All participants were 75/76 years of 
      age, were clinically free of AF, and had N-terminal pro b-type natriuretic 
      peptides levels >/=125 ng/L. AF screening was performed in parallel during a 2-week 
      period, using a continuous event recording device (R-test 4; Novacor) and 
      30-second intermittent recordings using a handheld ECG device (Zenicor II) four 
      times daily. Participants were asked to fill out a questionnaire with regard to 
      compliance and ease of use of the devices. RESULTS: During continuous event 
      recording, 6% (n = 15/269) were diagnosed with AF and intermittent ECG detected 
      AF in 2% (n = 5/269) of the participants (P = .002). No new cases of AF were 
      detected using intermittent ECG monitoring only, but some episodes were detected 
      in parallel for patients. On a graded ordinal scale of 1 to 5, with 1 reflecting 
      "very easy to use", continuous monitoring was graded 2 (interquartile range 
      [IQR]: 1-3) compared to intermittent 1 (IQR: 1-1) (P < .001). CONCLUSION: 
      Continuous event recording detected three times more AF compared to intermittent 
      ECG in an elderly ambulatory population. Compliance and user-friendliness were 
      rated higher for the intermittent ECG device.
CI  - (c) 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.
FAU - Fredriksson, Tove
AU  - Fredriksson T
AUID- ORCID: 0000-0003-2936-9998
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Kemp Gudmundsdottir, Katrin
AU  - Kemp Gudmundsdottir K
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Frykman, Viveka
AU  - Frykman V
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Friberg, Leif
AU  - Friberg L
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Al-Khalili, Faris
AU  - Al-Khalili F
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Engdahl, Johan
AU  - Engdahl J
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
FAU - Svennberg, Emma
AU  - Svennberg E
AD  - Department of Clinical Sciences, Danderyd University Hospital, Karolinska 
      Institutet, Stockholm, Sweden.
LA  - eng
GR  - Carl Bennet Ltd/
GR  - The Swedish Heart and Lung Foundation/
GR  - Roche Diagnostics/
GR  - Swedish Society of Medicine/
GR  - Swedish Heart and Lung Association/
GR  - Stockholm County Council/
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20200109
PL  - United States
TA  - Clin Cardiol
JT  - Clinical cardiology
JID - 7903272
SB  - IM
MH  - Age Factors
MH  - Aged
MH  - Atrial Fibrillation/*diagnosis/physiopathology
MH  - Electrocardiography, Ambulatory/*instrumentation
MH  - Female
MH  - *Heart Rate
MH  - Humans
MH  - Male
MH  - Patient Compliance
MH  - Patient Satisfaction
MH  - Predictive Value of Tests
MH  - Remote Sensing Technology/*instrumentation
MH  - Sweden
MH  - *Wearable Electronic Devices
PMC - PMC7144480
OTO - NOTNLM
OT  - ambulatory ECG
OT  - atrial fibrillation
OT  - electrocardiography
OT  - epidemiology
COIS- Tove Fredriksson has received unrestricted research grants from 
      Boehringer-Ingelheim and Stiftelsen Hjartat. Katrin Kemp Gudmundsdottir has 
      received a research grant from Stiftelsen Hjartat. Viveka Frykman has received 
      lecture fees from MSD, Boehringer-Ingelheim, Bayer, and Medtronic. Leif Friberg 
      has received consultancy fees from Bayer, Boehringer-Ingelheim, BMS/Pfizer, and 
      Sanofi. Faris Al-Khalili has received lecture fees from Bayer, 
      Boehringer-Ingelheim, and BMS/Pfizer. Johan Engdahl has received consultancy fees 
      from Sanofi and Pfizer; lecture fees from Bayer, Boehringer-Ingelheim, Astra 
      Zeneca, and Medtronic; and unrestricted research grants from Pfizer and 
      Boehringer-Ingelheim. Emma Svennberg has received lecture fees from Bayer, 
      Bristol-Myers Squibb-Pfizer, Boehringer- Ingelheim, and Sanofi.
EDAT- 2020/01/10 06:00
MHDA- 2020/12/22 06:00
PMCR- 2020/01/09
CRDT- 2020/01/10 06:00
PHST- 2019/10/09 00:00 [received]
PHST- 2019/12/08 00:00 [revised]
PHST- 2019/12/11 00:00 [accepted]
PHST- 2020/01/10 06:00 [pubmed]
PHST- 2020/12/22 06:00 [medline]
PHST- 2020/01/10 06:00 [entrez]
PHST- 2020/01/09 00:00 [pmc-release]
AID - CLC23323 [pii]
AID - 10.1002/clc.23323 [doi]
PST - ppublish
SO  - Clin Cardiol. 2020 Apr;43(4):355-362. doi: 10.1002/clc.23323. Epub 2020 Jan 9.